Kimberly C. Chen DO, MSHLM, and Maia Kayal, MD, MS, review the challenges related to biosimilars from the payer perspective and strategies payers may employ to help improve the uptake of biosimilars.
continue to see pushback in th streets. rachel, we thank you fo joining us on this, as always. want to continue thi conversation with dr. pate former senior policy directo to president obama and edmundson d.c. medical contributor. thank you for joining us i think from a physician standpoint, a scientific standpoint, looking at thi decision, obviously at the effects of taking mifepristone off the mark, about have o special disenfranchise community of women, black an brown women, that are seekin abortions across this country. also, kind of the fda approval process, right the fact the judge is weighing in on a drug that was approved by the fda, 23 years ago, with a 99% safety rating, right talk us through that approva process and your worries whe it comes to this yeah, it s not just the approval process, really ove the past few decades, there been an incredibly strict risk mitigation strategy in effec
create a slippery slope for fda approval. how might that argument play with the supreme court quest. the fda commissioner who oversaw the approval of the dru more than 20 years ago tells us tonight it is disturbing that the texas ruling could undermin public confidence and the fda approval process, which is the old standard to determine they are safe and the justices have been decided if they lean on this decision. thank you so much. in urgent search underway for three american sailors missing in mexico. family members say frank and carrie o brien along with william gross disappeared after leaving a resort town in mexico headed for san diego on a 44- foot sailboat. all ours had to be experienced sailors. tonight, the u.s. coast guar revealing those treacherous conditions leading up to the urgent search for three america sailors who disappeared 12 days ago. ticket they were significant.
of one of the pills that is used in medicated abortions. where a judge in washington state said no it can move forward. justice alito has put the texas ruling on hold for now. the biden administration is fighting it. they went to the court and said there will be chaos if women can t get access to the pill. now the justice has asked the other side to weigh in. they have to file their briefs by tuesday in this case. by wednesday, we could have a decision that quickly on what happens moving forward. remember, this isn t on the merits of the case about whether that pill s going to be available forever and ever and the fda approval process. this is just about whether that particular pill will be available while the case plays out on the merits through the lower courts. you know that can take months, even years, so both sides very much engaged in standing by for that decision this week. one in ten women who take that pill end up in emergency room. there are certainly some safety precaution
it says he has top secret security clearance. that tells me nothing. he could be either state national guard or federal national guard. i believe this is the next shoe to drop. i mean, i believe as we learn more, we will either determine you know, for reasons that are inexplicable to me that he was a state national guard member. having access to information as almost no relevance to a state national guard or possibly that he had been federalized under title 10 status, in which case the pentagon has a big problem right because he is reporting up the pentagon chain of command, and they should have had better oversight over him. and either case, let s just say it s not good. can you explain how the process works when somebody has top secret national security clearance because it seemed yesterday from the pentagon briefing that they were really focusing on the fact that he signed an n d, a and, and that in and of itself is sort of like the ball s in his court. he broke that agreement, and